At the end of 2012, Ian Boulton was asked to present on malaria diagnosis in the private retail sector at the 11th Assises Panafricaines de Lutte Contre le Paludisme (11th Pan-African National Malaria Control Programmes Meeting), sponsored and organised Sanofi, under the title:-
Mise à disposition des TDR dans le marché privé dans un contexte de T3;faisabilité, risques et opportunités?
(Availability of RDTs in the private market within the context of T3, feasibility challenges and opportunities)
This presentation built upon TMPC’s work on the Affordable Medicines Facility – malaria (AMFm) and the need to extend the use of diagnosis of malaria into the private market. This was also in the context of the launch of the World Health Organization’s “Test: Treat: Track” strategy for malaria.
More on the Test:Treat:Track (T3) strategy can be found at the WHO website: WHO: T3